Fellow of the Academy of Translational Medicine Professionals (FAcadTM), Translational Medicine
2015 - 2015
Ludwig-Maximilians Universität (LMU) Munich
Professional Certification in Biomarkers (PCB), Translational Medicine
2014 - 2014
Ludwig-Maximilians Universität (LMU) Munich
Professional Certification in Translational Medicine (PCTM) (Translational Medicine)
2013 - 2013
Ludwig-Maximilians Universität (LMU) Munich
Project Management Professional (PMP) (Project Management)
2010 - 2012
Ludwig-Maximilians Universität (LMU) Munich
Master of Science (Toxicology) (MSc) – European Registered Toxicologist (Toxicology)
2007 - 2010
Ludwig-Maximilians Universität (LMU) Munich
Master of Public Health (MPH) (Methodology and Statistics applied to Biomedical Research)
2005 - 2006
Ludwig-Maximilians Universität (LMU) Munich
CESAM (Inter-University Diploma in Methodology and Applied Statistics)
2004 - 2005
Ludwig-Maximilians Universität (LMU) Munich
Doctor medicinae veterinariae (PhD) (Veterinary Medicine)
2000 - 2003
Oliver Pohl's Skills
Clinical Pharmacology
Medical Writing
Medicine
Management
Translational Medicine
Molecular Biology
Medical Devices
Project Management
Biochemistry
Validation
Oliver Pohl's Summary
Oliver Pohl, based in Geneva, Switzerland, is currently a Director at Novartis, bringing experience from previous roles at STALICLA and ObsEva SA. Oliver Pohl holds a 1996 - 2002 Veterinary Surgeon in Veterinary Medicine @ Ludwig-Maximilians Universität (LMU) Munich. With a robust skill set that includes Clinical Pharmacology, Medical Writing, Medicine, Management, Translational Medicine and more, Oliver Pohl contributes valuable insights to the industry. Oliver Pohl has 3 emails on RocketReach.